NCT03984396View on ClinicalTrials.gov

Optimal Medication Management in Alzheimer's Disease and Dementia

NACompletedINTERVENTIONAL
Enrollment

7,398

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

April 1, 2021

Study Completion Date

January 31, 2024

Conditions
Dementia
Interventions
OTHER

Educational Materials - Patient & Clinician

deprescribing information for patient \& clinician

Trial Locations (1)

80014

Kaiser Permanente, Aurora

Sponsors

Collaborators (1)

Duke University
All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

Duke University

OTHER

collaborator

Monash University

OTHER

lead

Kaiser Permanente

OTHER

NCT03984396 - Optimal Medication Management in Alzheimer's Disease and Dementia | Biotech Hunter | Biotech Hunter